关于血管紧张素转换酶抑制药+β受体阻断药组合的重新审视

A Review on the Joint Use of Angiotensin Converting Enzyme Inhibitors and β-receptor Blockers

采取联合用药方案治疗高血压已成为近年来临床用药的总体趋势。临床用药情况调查结果表明,血管紧张素转换酶抑制药+β受体阻断药的联合用药组合占有一定的使用率,分析两类药的降压作用以及对高血压常见并发症和对代谢、心率等的影响,可见这个组合是合理的。

The joint use of medicines in treating hypertension has become the common tendency in the clinical treatment. Recent clinic studies over the medicine dosage manifest that, β-receptor blockers and the angiotensin converting enzyme inhibitors, are used to a certain extent. It can be concluded that the joint use of the two kinds of medicines is reasonable from the discussion on their functions of treating hypertension and complications, and their influences over metabolism and heart rate.